White Paper: Application Of Electronic Records & Signatures In Calibration Management Software
Effective August 20, 1997, the Food and Drug Administration (FDA) issued 21 CFR Part
11, setting forth criteria under which the agency will accept, under certain circumstances,
electronic records and electronic signatures as equivalent to paper records and
handwritten signatures. Part 11 allows firms to take advantage of electronic technology,
and to have electronic records considered equivalent to traditional paper records.
access the White Paper!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
This website uses cookies to ensure you get the best experience on our website. Learn more